Congestion
发表于 2025-3-25 03:24:44
http://reply.papertrans.cn/87/8632/863106/863106_21.png
Mediocre
发表于 2025-3-25 08:59:19
http://reply.papertrans.cn/87/8632/863106/863106_22.png
愚笨
发表于 2025-3-25 11:54:45
http://reply.papertrans.cn/87/8632/863106/863106_23.png
护身符
发表于 2025-3-25 19:10:46
http://reply.papertrans.cn/87/8632/863106/863106_24.png
难听的声音
发表于 2025-3-25 20:46:06
Dinghui Zou,Kunshan Gaosianic figure. As their life becomes unbearable, “revolution” would become desirable. One of the ways of creating a revolution is by creating the ideal of Apocalypse, a messianic figure who embodies the people’s hope. In Hebraic religions, we see such great icons of hope represented by the prophets
cortex
发表于 2025-3-26 03:19:56
Rafael Riosmena-Rodriguez,Marco A. Medina-López limbs (legs, arms) from the sides of the statues to conjure an image that they indeed were alive. Since these statues were ., Daedalus would subsequently bind them as if to prevent them from walking away (see also, Euripides: . 838; Aristophanes: . frag. 194).
破译
发表于 2025-3-26 04:46:24
Félix L. Figueroa,Nathalie Korbeeicularly relevant to the patenting of peptide vaccines and therapeutic peptides as products and in compositions. The scope of patentable subject matter is discussed, as it has been the focus of much wrangling and debate in the courts..978-3-642-29525-6978-3-642-29526-3Series ISSN 2192-9904 Series E-ISSN 2192-9912
Subjugate
发表于 2025-3-26 11:53:53
http://reply.papertrans.cn/87/8632/863106/863106_28.png
多节
发表于 2025-3-26 14:04:27
E. Walter Helbling,Virginia E. Villafañe,Donat-P. Häderroach are rather different for the two patent offices. Topics of mosquito prevention methods, such as a net and diagnostic tool, were found only in the SIPO, while in the USPTO, topics for specific vaccines in different stages were identified. In both, the SIPO and USPTO, topics of malarial medicine
镶嵌细工
发表于 2025-3-26 17:38:25
wering the standard to prove patent invalidity) on biopharmaceutical innovations and provides future perspectives for proper balancing of the patent social contract with a move from a litigation-focused to an innovation-focused patent system for biopharmaceutical drug development.